FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula
or 
or to their pharmaceutically acceptable salts, where ring A, R2, R3, R4 and X are as defined in the description. The disclosed compounds are useful as 11βHSD1 inhibitor. The invention also relates to a pharmaceutical composition, an agent for treating or preventing pathology related to glucocorticoids, a 11βHSD1 inhibitor containing the disclosed compound or its pharmaceutically acceptable salt, and use of the disclosed compounds.
EFFECT: compounds are highly effective.
40 cl, 48 tbl, 191 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3-ALKYLIDENHYDRAZINO-HETEROARYL COMPOUNDS AS ACTIVATORS OF THROMBOPROTEIN RECEPTOR | 2004 |
|
RU2358970C2 |
| PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2340611C2 |
| CARBOSTYRIL COMPOUND | 2005 |
|
RU2430920C2 |
| OXYGEN-SUBSTITUTED DERIVATIVES OF 3-HETEROAROYLAMINOPROPIONIC ACIDS AND THEIR APPLICATION AS PHARMACEUTICAL SUBSTANCES | 2011 |
|
RU2561126C2 |
| MACROCYCLIC HEPATITIS TYPE C VIRUS INHIBITORS | 2006 |
|
RU2419619C2 |
| (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | 2012 |
|
RU2681211C2 |
| HETEROCYCLIC COMPOUND | 2019 |
|
RU2815003C2 |
| AMINO-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND USE THEREOF AS PHARMACEUTICAL AGENTS | 2012 |
|
RU2605600C2 |
| PYRAZOLE[1,5-a]PYRIMIDINE DERIVATIVE | 2006 |
|
RU2390523C2 |
| NOVEL COMPOUND HAVING PARP INHIBITORY ACTIVITY | 2012 |
|
RU2606635C2 |
